Aspira Women's Health Inc. Appoints New CFO and CAO

Aspira Women's Health Inc. announced the appointment of John Strahley as Chief Financial Officer and Chief Accounting Officer, effective April 27, 2026. This appointment follows the termination of Brian Hungerford's consulting agreement as CFO, effective April 26, 2026. Mr. Strahley, with extensive financial leadership experience in life sciences, will serve in a fractional capacity, working a minimum of twenty hours per week. His compensation includes an annualized base salary of $167,000 and an option to purchase 70,000 shares of the Company's common stock, with vesting conditions and accelerated vesting upon a Change in Control. Mr. Hungerford departs for personal reasons, and the company expressed gratitude for his service.